Results 181 to 190 of about 1,072,260 (332)

Bypass surgery in a Jehovah's Witness with critical limb ischemia and end stage renal disease: a case report. [PDF]

J Surg Case Rep
Choi E.
europepmc   +1 more source

MEDICAL WITNESSES ACT. [PDF]

J.E. Brinsden
openalex   +1 more source

The Early Editorial Policy of the Montreal Witness [PDF]

, 1947
Julie Cooper
openalex   +1 more source

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

Molecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche, Renske Imschoot, Béatrice Lintermans, Lode Denolf, Joachim Taminau, Charlotte Fieuws, Geert Berx, Kris Gevaert, Kathleen B. M. Claes   +8 more
wiley   +1 more source

The Presence of Family Members During Brainstem Testing: An Ethical Dilemma. [PDF]

Nurs Crit Care
McEvoy NL, Geoghegan P, Downey S, Latour J, Gaffney A, O'Rourke J, Curley GF.   +6 more
europepmc   +1 more source

Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer

Molecular Oncology, EarlyView.
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner, Markus Eckstein, Christoph Mark, Matthias W. Beckmann, Arndt Hartmann, Pamela L. Strissel, Reiner Strick   +6 more
wiley   +1 more source

Familiarity Gates Socially Transmitted Aggression via the Medial Amygdala. [PDF]

J Neurosci
Adjei MP, Qasem E, Aaflaq S, Jacobs JT, Skinner S, Summa F, Spotanski C, Thompson R, Aholt ML, Lineberry T, Nordman JC.   +10 more
europepmc   +1 more source

Witnesses: Privilege against Self-Incrimination

, 1913

openalex   +2 more sources

Self Incrimination by Federal Grand Jury Witnesses: Uniform Protection Advocated [PDF]

, 1958

openalex   +1 more source

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

Molecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva, Bernardo Orr, Ana Azeredo, Andreia Brandão, Manuel R. Teixeira, Paula Paulo   +5 more
wiley   +1 more source